The clinical outcomes of percutaneous coronary intervention in chronic total coronary occlusion

Ugur Arslan1, Akif Serhat Balcioglu, Timur Timurkaynak

  • 1Department of Cardiology, Gazi University School of Medicine, Ankara, Turkey.

Insights

Percutaneous coronary intervention (PCI) for chronic total coronary occlusion (CTO) shows a significant mortality benefit, despite challenges like restenosis. Successful PCI reduces deaths from heart failure and sudden cardiac events.

Area of Science:

  • Cardiology
  • Interventional Cardiology

Background:

  • Chronic total coronary occlusion (CTO) presents a significant challenge in managing stable coronary artery disease.
  • Percutaneous coronary intervention (PCI) is a common revascularization strategy, but its efficacy in CTO remains debated.

Purpose of the Study:

  • To evaluate the impact of PCI on major adverse cardiac events in patients with CTO.
  • To assess the long-term mortality outcomes associated with successful PCI in CTO patients.

Main Methods:

  • Retrospective analysis of 262 patients with CTO and stable coronary artery disease.
  • Comparison of outcomes between patients undergoing PCI and those managed conservatively.
  • Assessment of procedural success rates, restenosis, and mortality.

Main Results:

  • Successful PCI was achieved in 117 out of 172 attempted cases (68.0%).
  • A significant reduction in all-cause mortality was observed in patients with successful PCI compared to the conservative group (14.5% vs. 27.8%, P=0.013).
  • Lower rates of death from heart failure (6.0% vs. 14.8%, P=0.028) were noted in the successful PCI group.

Conclusions:

  • Despite a notable rate of restenosis, PCI for CTO offers a significant mortality benefit.
  • Revascularization of CTO through PCI is a worthwhile strategy for improving long-term survival.
  • Further research into optimizing PCI techniques for CTO is warranted.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...